Posted On: Monday, November 2nd, 2015
We will be wrapping up our two-year recruitment period at the end of December, 2015. Please ask anyone you know who may be eligible to give us a call before then so that they can be included in this important research. So far, we’ve enrolled 86 individuals in the study and done qualitative interviews with 20 of those individuals…. Read more »
Posted On: Monday, October 26th, 2015
by MCM Murray, MD, PhD, FRCPC, Infectious Disease Specialist, BC Women’s and St. Paul’s Hospitals, Assistant Professor, University of British Columbia. Background Since its introduction in 1996, combined anti-retroviral therapy (cART) has led to enormous improvements in the health and survival of HIV positive (HIV+) persons. However, the success of cART is intrinsic upon patient… Read more »
Posted On: Monday, October 26th, 2015
The Canadian Agency for Drugs and Technologies in Health (CADTH) wants to hear from you! They are currently seeking patient input for grazoprevir / elbasvir and, therefore, the Pacific Hep C Network (PHCN) needs your thoughts, opinions, and experiences for our patient group input report. There are two PHCN Input Surveys Take this survey if… Read more »
Posted On: Monday, October 19th, 2015
Vancouver, BC [October 5, 2015] HIV testing in parts of Canada remains based on “perceived risk” and could be keeping people living with the disease from discovering their status. A new study, based on the largest Canadian database of people living with HIV, finds nearly half of those surveyed started antiretroviral treatment (ART) when they… Read more »
Posted On: Monday, October 19th, 2015
New and Noteworthy High cure rates for people on opiate substitution therapy with Holkira Pak A small, mid-stage clinical trial of participants on opioid substitution therapy (OST) who took Holkira Pak and ribavirin for 12 weeks had a cure rate of 97% reported researchers in the Journal of Hepatology. OST is taken by people who… Read more »
Posted On: Thursday, October 15th, 2015
The Pacific AIDS Network is pleased to announce that the study has been officially launched in all three of its case study communities. Study site coordinators in Prince George and Greater Vancouver (Devyn Flesher and Mona Lee) have been interviewing people living with HIV (PLHIV), as well as service providers and policy makers, since the… Read more »
Posted On: Tuesday, October 13th, 2015
Long-held assumptions about controversial issues such as drug use can lead to ineffective or even harmful policies and programming. The BC-CfE’s Urban Health Research Initiative (UHRI), under the leadership of co-directors Dr. Evan Wood and Dr. Thomas Kerr, offers an evidence-approach to challenging problems facing urban communities. UHRI’s studies focus on topics such as substance… Read more »
Posted On: Wednesday, October 7th, 2015
Have you ever wondered what the literature says about community-based organizations’ (CBOs) impact on the HIV sector? How do CBOs support people living with HIV? What makes the services and programs CBOs provide unique? The Ontario HIV Treatment Network has just completed a Rapid Response examining the question: What is the impact of community-based organization (CBOs) in… Read more »
Posted On: Monday, October 5th, 2015
CATIE is Canada’s source for up-to-date, unbiased information about HIV and hepatitis C. CATIE is reaching out to people living with HIV to find out what kinds of information they need and how well CATIE is doing at meeting these needs. Start the survey now If you are living with HIV, please take a few… Read more »
Posted On: Thursday, October 1st, 2015
While media headlines focus on individuals prosecuted for alleged HIV non-disclosure, we know that the impacts of criminalizing HIV non-disclosure go far beyond those who are formally charged. I was therefore delighted to learn in April that our 3-year community-based research (CBR) proposal to the Canadian Institutes of Health Research had been approved. Titled “Women… Read more »
Posted On: Sunday, September 27th, 2015
People who have been exposed to HIV may prevent this virus from being established by taking post-exposure prophylaxis (PEP). This involves starting anti-HIV medicines within 72 hours of exposure and continuing to take these medicines every day for 28 consecutive days. Continually resorting to PEP is not the best way to prevent HIV, so doctors… Read more »
Posted On: Tuesday, September 22nd, 2015
Working with collaborators from British Columbia, the OHTN’s Applied Epidemiology Unit has released a new report on health literacy, sexual health and gay men. Health literacy means having the skills to find, understand, evaluate and talk about health information with others. In Canada, gay men were one of the first groups affected by HIV, and they… Read more »
